- Home
- SINT vs APM Comparison
SINT vs APM Comparison
Compare SINT & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- APM
- Stock Information
- Founded
- SINT 1996
- APM 2010
- Country
- SINT United States
- APM United Kingdom
- Employees
- SINT 20
- APM N/A
- Industry
- SINT Medical/Dental Instruments
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- APM Health Care
- Exchange
- SINT Nasdaq
- APM Nasdaq
- Market Cap
- SINT 8.3M
- APM 6.9M
- IPO Year
- SINT 2014
- APM 2018
- Fundamental
- Price
- SINT $3.04
- APM $1.39
- Analyst Decision
- SINT Strong Buy
- APM
- Analyst Count
- SINT 1
- APM 0
- Target Price
- SINT $28.00
- APM N/A
- AVG Volume (30 Days)
- SINT 65.3K
- APM 189.0K
- Earning Date
- SINT 08-14-2025
- APM 08-26-2025
- Dividend Yield
- SINT N/A
- APM N/A
- EPS Growth
- SINT N/A
- APM N/A
- EPS
- SINT N/A
- APM N/A
- Revenue
- SINT $1,861,000.00
- APM N/A
- Revenue This Year
- SINT N/A
- APM N/A
- Revenue Next Year
- SINT $87.50
- APM N/A
- P/E Ratio
- SINT N/A
- APM N/A
- Revenue Growth
- SINT N/A
- APM N/A
- 52 Week Low
- SINT $1.71
- APM $0.46
- 52 Week High
- SINT $8.60
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- SINT 58.68
- APM 49.96
- Support Level
- SINT $2.85
- APM $1.21
- Resistance Level
- SINT $3.13
- APM $1.47
- Average True Range (ATR)
- SINT 0.19
- APM 0.12
- MACD
- SINT 0.06
- APM -0.03
- Stochastic Oscillator
- SINT 89.02
- APM 35.29
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.